newsfilter
← Latest News
Business Wire·

Infinity to Participate in Wells Fargo and H.C. Wainwright Investor Conferences

Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) ("Infinity" or the "Company"), a clinical-stage biotechnology company developing eganelisib, a first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, today announced that the Company will